Attaining optimal blood glucose management in patients with type 2 diabetes is important to improve both short-term and long-term health outcomes. A sustained legacy effect of intensive glucose-management in type 2 diabetes has been observed, indicating a continued reduction in microvascular risk. In addition, the legacy effect demonstrates an association between intensive glucose management and a significantly decreased risk of myocardial infarction and death.<\/p>\n
A general glycaemic target of HbA1c = 7% (53mmol\/mol) has therefore been recommended for newly diagnosed and uncomplicated patients. Over 60% of patients, however, are reported as not achieving their glycaemic goals. One Australian study showed less than half of patients with type 2 diabetes seen in general practice had an HbA1c = 7% (53 mmol\/mol) with 25% having an HbA1c > 8% (64mmol\/mol). Current glycaemic management seems to be \u201cmissing the target\u201d of accepted treatment goals.<\/p>","protected":false},"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-82329","eb_course","type-eb_course","status-publish","hentry"],"acf":[],"yoast_head":"\n